Market Cap: $14.18B
IC
ICON Public Limited Company
ICLR
NASDAQUSD
Market Cap: $14.18B
Icon Plc Poised for Growth Amid Positive Industry Shifts In recent developments, Wall Street analysts highlight a significant upgrade for Icon Plc (ICLR) from BMO, raising its rating to "outperform."…
Analysts’ Divergent Views Reflect Complex Landscape for Icon Plc In recent weeks, analysts offer a mixed bag of opinions on Icon Plc (NASDAQ: ICLR), a prominent player in the clinical research outsour…
### Navigating the Diverging Analyst Ratings for Icon Plc In the past three months, five independent analysts evaluate Icon Plc's (NASDAQ: ICLR) performance, revealing a blend of optimistic and cautio…
CROs see rising demand as drugmakers chase expedited FDA pathways Clinical research organisations including Icon Plc are seeing increased demand as biopharma companies pursue expedited regulatory rout…
Headline: Clinical research firms weigh naming clients when summarising Breakthrough Therapy developments Introduction — Communication choices shape programme visibility A recent exchange about whethe…
Icon Plc Confronts Rising Complexity from Breakthrough Designations and Combination Therapies Clinical trial services provider Icon Plc is seeing growing demand as pharmaceutical developers increasing…
ICON Audit Committee probes revenue recognition and controls ICON plc is conducting an internal Audit Committee investigation into its revenue recognition practices and internal control over financial…
Audit Spotlight: ICON’s Revenue Recognition Inquiry Audit Committee Investigates 2023–2025 Revenue and Controls ICON plc’s internal Audit Committee is conducting an ongoing investigation into the comp…
Icon Plc’s Strategic Focus Ahead of Quarterly Earnings Report As Icon Plc prepares to unveil its quarterly earnings report on October 22, 2025, the spotlight remains firmly on its robust growth in the…
Navigating Mixed Sentiments in Clinical Research: Icon Plc’s Current Landscape Icon Plc, a prominent player in the healthcare and clinical research industry, experiences a diverse array of analyst rat…
Icon Plc Sees Upgraded Prospects Amid Market Optimism In a notable development within the clinical research industry, Rothschild & Company Redburn has upgraded Icon Plc to a "buy" rating, signaling re…
Icon Plc: Navigating Analyst Sentiments Amid Industry Dynamics Icon Plc (ICLR), a prominent player in the clinical research and healthcare sector, currently faces a spectrum of analyst ratings that re…
ICON plc’s Strong Q2 Results Showcase Growth in Clinical Research Services ICON plc, a prominent player in the clinical research organization sector, reports robust second-quarter financial results th…
ICON plc's Strategic Growth in Clinical Research: A Positive Outlook for 2025 ICON plc, a leading clinical research organization, showcases its strong financial performance in the second quarter by ex…
Investment Strategy Shifts: Klarman's Focus on Undervalued Assets In a notable move within the investment landscape, Seth Klarman, head of the Baupost Group, reveals a concentrated strategy on underpe…
Investing in Healthcare: A Strategic Move for Icon Plc Amid Market Challenges In the recent investment landscape, Icon Plc, a leading Irish healthcare firm, captures attention as it receives a signifi…
ICON PLC Faces Class Action Lawsuit Amid Allegations of Misleading Statements ICON Public Limited Company, a prominent player in the contract research organization (CRO) sector, finds itself at the ce…
Legal Challenges Loom for ICON Plc Amid Class Action Lawsuit In a significant legal development, ICON Public Limited Company faces a class action lawsuit filed by the Schall Law Firm, alleging violati…
Allegations of Misleading Statements Spark Class Action Against Icon Plc Icon Public Limited Company (NASDAQ: ICLR) faces a class action lawsuit as the Schall Law Firm accuses the company of violating…
ICON Public Limited Company Faces Class Action Lawsuit Amid Allegations of Misleading Statements In a significant legal development, Kessler Topaz Meltzer & Check, LLP announces a securities class act…
Legal Challenges Ahead for ICON Plc Amidst Allegations of Misleading Statements A recent class action lawsuit against ICON Public Limited Company (NASDAQ: ICLR) has raised significant concerns regardi…
Legal Challenges Loom for ICON plc Amid Class Action Lawsuit ICON plc faces significant legal scrutiny as the Law Offices of Howard G. Smith remind investors of an impending April 11, 2025, deadline t…
Allegations of Misleading Statements Prompt Class Action Lawsuits Against ICON plc In recent days, multiple law firms have filed class action lawsuits against ICON plc (NASDAQ: ICLR), alleging the com…
Legal Challenges Loom for ICON plc Amid Allegations of Misleading Statements In recent developments, ICON plc (NASDAQ: ICLR) faces multiple class action lawsuits filed by shareholders who purchased sh…
ICON plc Expands AI Tools to Enhance Clinical Trial Efficiency ICON plc, a prominent clinical research organization, is making significant strides in the integration of artificial intelligence (AI) in…